Phase I Trial HIPEC With Nal-irinotecan
Learn more about:
Related Clinical Trial
Severe Neutropenia After HIPEC Using Mitomycin-C
Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients
Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei
A Study of SGN-STNV in Advanced Solid Tumors
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
Thrombin Generation and Platelet Activation in CRS/HIPEC
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
French National Registry of Rare Peritoneal Surface Malignancies
Peritoneal Surface Malignancies – Characterization, Models and Treatment Strategies
Phase I Trial HIPEC With Nal-irinotecan
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Gastrointestinal Microbiome Study of Appendiceal Cancer
Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Injection of Bromelain and Acetylcysteine in Combination Into Recurrent Mucinous Tumour or Pseudomyxoma Peritonei
Results of CRS and Debulking in PMP Patients
What Are the Experiences of Patients With Pseudomyxoma Peritonei?
HIPEC Using High Intra-abdominal Pressure